Last reviewed · How we verify

Polihexanide 2% — Competitive Intelligence Brief

Polihexanide 2% (Polihexanide 2%) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiseptic/Antimicrobial agent. Area: Infectious Disease / Wound Care.

phase 3 Antiseptic/Antimicrobial agent Infectious Disease / Wound Care Small molecule Live · refreshed every 30 min

Target snapshot

Polihexanide 2% (Polihexanide 2%) — University of Sao Paulo. Polihexanide is a broad-spectrum antimicrobial agent that disrupts bacterial and fungal cell membranes through electrostatic interactions.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Polihexanide 2% TARGET Polihexanide 2% University of Sao Paulo phase 3 Antiseptic/Antimicrobial agent
Irrigation with PVI Irrigation with PVI The University of Texas Health Science Center, Houston marketed Antiseptic/Antimicrobial agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiseptic/Antimicrobial agent class)

  1. The University of Texas Health Science Center, Houston · 1 drug in this class
  2. University of Sao Paulo · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Polihexanide 2% — Competitive Intelligence Brief. https://druglandscape.com/ci/polihexanide-2. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: